Biocon on Monday said its unit Biocon Biologics has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at ...
The Economic Times
4 days ago
CNBC Awaaz
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker hardsells airport play
3 hours ago
IBTmes India
Biocon Biologics gets EMA nod to manufacture cancer drug in India
Biocon gets 4 observations from USFDA for Andhra facility
6 days ago
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
F&O stocks to buy today: ICICI Bank, Biocon among top 6 trading ideas for 27 June 2024
1 day ago
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹351.30 +5.15 (+1.49%)
Fri, Jun 28, 2024, 5:35AM EDT